Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity
2015
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
2010 StandoutScience
Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant
2011
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
2015 StandoutNobel
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab
2008
Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell Immunotherapies
2015
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
2006 StandoutScience
Adiponectin Receptor Signaling on Dendritic Cells Blunts Antitumor Immunity
2014
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions
2008
Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in Humans
2010
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Proceedings from the National Cancer Institute’s Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part III. Prevention and Treatment of Relapse after Allogeneic Transplantation
2013
Cancer immunotherapy: the beginning of the end of cancer?
2016
Engineering precision nanoparticles for drug delivery
2020 Standout
PR1 vaccination in myeloid malignancies
2008
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
2014 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Autobiographical memory specificity and emotional disorder.
2007
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Stem Cell Transplantation for Indolent Lymphoma and Chronic Lymphocytic Leukemia
2010
WT1 peptide vaccine for the treatment of cancer
2008
Hydrophobic mismatch drives self-organization of designer proteins into synthetic membranes
2024 StandoutNobel
Functional differences between low- and high-affinity CD8+T cells in the tumor environment
2012
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology
2013
The emerging role of lncRNAs in cancer
2015 Standout
Can Only Partial T-Cell Depletion of the Graft before Hematopoietic Stem Cell Transplantation Mitigate Graft-versus-Host Disease While Preserving a Graft-versus-Leukemia Reaction? A Prospective Phase II Study
2006
Genetic engineering of T cells for immunotherapy
2021
18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response
2009
X-Inactivation, Imprinting, and Long Noncoding RNAs in Health and Disease
2013
Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic
2015
NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs
2005
Inhibition of Interleukin-10 in the tumor microenvironment can restore mesothelin chimeric antigen receptor T cell activity in pancreatic cancer in vitro
2018
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
2015
Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath ‘in the bag’ as T-cell depletion: the Leiden experience
2006
Graft-versus-host disease
2009 Standout
Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?
2007
Engineering CAR-T cells: Design concepts
2015
Programmable synthetic receptors: the next-generation of cell and gene therapies
2024
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Sickle-cell disease
2010 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
2008
Understanding and harnessing the graft‐versus‐leukaemia effect
2008
Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease
2009
Delivery technologies for T cell gene editing: Applications in cancer immunotherapy
2021
THREE PARIETAL CIRCUITS FOR NUMBER PROCESSING
2003 Standout
Constructive and unconstructive repetitive thought.
2008 Standout
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
2003 Standout
Therapeutic Vaccination for HPV Induced Cervical Cancers
2007
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
The PI3K Pathway in Human Disease
2017 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes
2016 StandoutNobel
Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells
2015
Long Noncoding RNAs: Cellular Address Codes in Development and Disease
2013 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
Chimeric antigen receptor T-cell therapies for lymphoma
2017
Synthetic Messenger RNA as a Tool for Gene Therapy
2006
Adoptive Immunotherapy for Cancer or Viruses
2014
TGF-β in allogeneic stem cell transplantation: friend or foe?
2005
Role of Functional Imaging in the Management of Lymphoma
2011
Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation
2013
Acute Myeloid Leukemia
2015 Standout
Enhanced Antitumor Activity of Murine-Human Hybrid T-Cell Receptor (TCR) in Human Lymphocytes Is Associated with Improved Pairing and TCR/CD3 Stability
2006
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Immunometabolism governs dendritic cell and macrophage function
2015 Standout
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Present and future therapies of hepatitis B: From discovery to cure
2015
Lack of specific γ-retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulation
2009
Graft-versus-leukemia effects of transplantation and donor lymphocytes
2008
Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study
2005
Chimeric Antigen Receptor Therapy
2018 Standout
Delivery technologies for genome editing
2017
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma
2014
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cells
2014
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia
2007
Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men
2006
Redirecting αβT cells against cancer cells by transfer of a broadly tumor-reactive γδT-cell receptor
2011
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma
2009
Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Advanced Chronic Lymphocytic Leukemia
2005
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Psychiatric epigenetics: a new focus for the new century
2000
Nontoxic nanopore electroporation for effective intracellular delivery of biological macromolecules
2019 StandoutNobel
Works of Emma Morris being referenced
Donor treatment with pegylated-G-CSF augments the generation of IL-10 producing regulatory T cells and promotes transplant tolerance
2004
Targeting the Wilms Tumor Antigen 1 by TCR Gene Transfer: TCR Variants Improve Tetramer Binding but Not the Function of Gene Modified Human T Cells
2007
Monoclonal T-Cell Receptors: New Reagents for Cancer Therapy
2007
Immunomodulation in the treatment of haematological malignancies
2009
Retroviral transfer of a dominant TCR prevents surface expression of a large proportion of the endogenous TCR repertoire in human T cells
2008
Autobiographical memory and post‐psychotic depression in first episode psychosis
2004
Distinctive patterns of memory function in subgroups of females with Turner syndrome: evidence for imprinted loci on the X-chromosome affecting neurodevelopment
2000
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation
2005
Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient
2014
Molecular immunology lessons from therapeutic T‐cell receptor gene transfer
2010
Expansion of Anti-Mesothelin Specific CD4+ and CD8+ T Cell Responses in Patients with Pancreatic Carcinoma
2014
Use of 18F‐FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions
2005
Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: Limited efficacy of graft-versus-tumor activity
2003
Comparison of Lentiviral and Sleeping Beauty Mediated αβ T Cell Receptor Gene Transfer
2013
Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice
2009
WT1-specific T cell receptor gene therapy: Improving TCR function in transduced T cells
2007
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy
2021
Generation of tumor-specific T-cell therapies
2005
Immunotherapy with gene-modified T cells: limiting side effects provides new challenges
2013
Generation of multi-functional antigen-specific human T-cells by lentiviral TCR gene transfer
2010
Adoptive T-Cell Therapy for Cancer in the United Kingdom: A Review of Activity for the British Society of Gene and Cell Therapy Annual Meeting 2015
2015
Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen
2011
HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning
2010
Optimizing T-cell receptor gene therapy for hematologic malignancies
2016
CD3 limits the efficacy of TCR gene therapy in vivo
2011
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma
2004
Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses
2003
Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications
2003
Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene–transduced human T cells
2005
Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma
2010
Favorable Long-Term Survival After Reduced-Intensity Allogeneic Transplantation for Multiple-Relapse Aggressive Non-Hodgkin's Lymphoma
2008
A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection
2005
Donor Lymphocyte Infusions Modulate Relapse Risk in Mixed Chimeras and Induce Durable Salvage in Relapsed Patients After T-Cell–Depleted Allogeneic Transplantation for Hodgkin's Lymphoma
2011
Exploiting T cell receptor genes for cancer immunotherapy
2004